2,3-pentanedione has been researched along with Fibrosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flake, GP; Foley, JF; Gerrish, KE; Gwinn, WM; Kelly, FL; Merrick, BA; Morgan, DL; Palmer, SM; Stockton, PS; Ton, TV; Wang, Y | 1 |
Flake, GP; Gwinn, WM; Jokinen, MP; Morgan, DL; Palmer, SM; Price, HC | 1 |
2 other study(ies) available for 2,3-pentanedione and Fibrosis
Article | Year |
---|---|
Gene expression in obliterative bronchiolitis-like lesions in 2,3-pentanedione-exposed rats.
Topics: Animals; Bronchi; Bronchiolitis Obliterans; Disease Models, Animal; Down-Regulation; Fibrosis; Immunohistochemistry; Inhalation Exposure; Male; Pentanones; Principal Component Analysis; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; RNA; Transforming Growth Factor beta2; Up-Regulation | 2015 |
Bronchial and bronchiolar fibrosis in rats exposed to 2,3-pentanedione vapors: implications for bronchiolitis obliterans in humans.
Topics: Administration, Inhalation; Analysis of Variance; Animals; Body Weight; Bronchiolitis; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Female; Fibrosis; Immunohistochemistry; Larynx; Male; Mice; Nasal Cavity; Nasal Mucosa; Necrosis; Organ Size; Pentanones; Rats; Rats, Wistar; Toxicity Tests | 2012 |